Last reviewed · How we verify
Acetylsalicylate
At a glance
| Generic name | Acetylsalicylate |
|---|---|
| Sponsor | Helse Stavanger HF |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Prevalence of Aspirin Resistance in Ischemic Stroke Patients at Assiut University Hospital
- Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms (PHASE3)
- Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) (PHASE3)
- Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone (PHASE3)
- Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients (PHASE2, PHASE3)
- BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) (PHASE3)
- Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease (EARLY_PHASE1)
- Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetylsalicylate CI brief — competitive landscape report
- Acetylsalicylate updates RSS · CI watch RSS
- Helse Stavanger HF portfolio CI